Hamann, Philip R <br/><br/>
Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.  [electronic resource] 

 -  Bioconjugate chemistry   
 - 47-58 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1043-1802 
<br/><br/><label>Standard No.: </label>10.1021/bc010021y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aminoglycosides<br/>Animals<br/>Anti-Bacterial Agents--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antigens, CD--immunology<br/>Antigens, Differentiation, Myelomonocytic--immunology<br/>Cross-Linking Reagents<br/>Gemtuzumab<br/>HL-60 Cells<br/>Humans<br/>Immunotoxins--therapeutic use<br/>Indicators and Reagents<br/>Leukemia, Myeloid--drug therapy<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Sialic Acid Binding Ig-like Lectin 3<br/>Tumor Cells, Cultured